How should a life sciences company choose an IT provider in Massachusetts?

Choose based on measurable response SLAs, security controls included (MFA/EDR/backups), cloud expertise, experience with compliance and due diligence, and clear fixed-fee pricing. Ask how they document controls for partners and investors.

What questions should biotech leaders ask an MSP about cybersecurity?

Ask which security tools are included, how MFA is enforced, how backups are tested, how incidents are handled, and what reporting you will receive. Also ask how they support investor questionnaires and audit logging.

What are red flags when selecting a managed IT partner for biotech?

Red flags include vague security answers, unclear responsibilities, weak backup testing, no documentation process, and inability to explain cloud security clearly. In life sciences, lack of due diligence readiness can slow partnerships and funding.

Choose IT Provider - Life Sciences | First Class Networks

Investors increasingly evaluate cybersecurity posture before funding biotech and medical device companies. A weak security framework can delay funding or reduce valuation. Preparing for cybersecurity due diligence typically requires 3–6 months of structured remediation, with readiness investments ranging from $25,000–$100,000+ depending on maturity.

What Investors Look For

SOC 2 readiness
Documented risk assessments
Incident response plans
MFA enforcement
Backup & disaster recovery documentation

Common Gaps Found During Due Diligence

No centralized logging
Weak vendor management
Lack of formal policies
Incomplete documentation

Step-by-Step Preparation Framework

Perform cybersecurity risk assessment
Implement MFA & EDR
Document policies
Test incident response
Conduct internal audit

Real Example

A 30-employee biotech startup completed structured remediation over 4 months at approximately $65,000 total cost and successfully cleared institutional investor cybersecurity review.